Oxford Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,400
Closed -$11.9M 287
2023
Q4
$11.9M Hold
20,400
0.87% 21
2023
Q3
$11M Buy
+20,400
New +$10.5M 0.95% 19

Other funds holding LLY

Oxford Financial Group's LLY Position: Q2 2026 in Review

Oxford Financial Group reduced its Eli Lilly (LLY) stake by 0.58% in Q2 2026, selling an estimated $773K and leaving 128,862 shares worth $155M. The position accounts for 7.83% of the portfolio, ranked #4.

Oxford Financial Group first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. The position peaked at $275M in Q1 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oxford Financial Group held 128,862 shares of Eli Lilly worth $155M as of Q2 2026.
  • Oxford Financial Group sold 757 Eli Lilly shares in Q2 2026, an estimated $773K.
  • Eli Lilly made up 7.83% of Oxford Financial Group's portfolio in Q2 2026, its #4 holding.
  • Oxford Financial Group first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • Oxford Financial Group's Eli Lilly position peaked at $275M in Q1 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oxford Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.